According to a recent study conducted bu Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, and published in November 2010 issue of Arthritis & Rheumatism, the drug Etanercept with or without methotrexate may help restore normal growth in children with juvenile idiopathic arthritis (JIA).
Methotrexate alone was not found effective in this aspect.
Juvenile idiopathic arthritis, earlier known as juvenile rheumatoid arthritis is associated with chronic inflammation, that results in impaired growth and development and functional joint involvement.
The current study included determining height, weight, and body mass index (BMI) at baseline and each year thereafter for 3 years and was based on patient registry.
The evidence in the current paper may encourage clinicians to initiate etanercept earlier in the disease course to try to avert growth retardation.
Arthritis Rheum. 2010;62:3259-3264.
Popularity: 1% [?]
Join Discussions